Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical companies, including the makers of Xarelto, possess a duty to make sure that their drugs are reasonably protected for use - and failure to complete so may possibly be grounds for compensation. Our lawyers are operating difficult to obtain these hurt by the drug the compensation they may be entitled to.













image class="left" url="https://images56.fotki.com/v127/photos/2/3651632/13703394/reltosideeffectsbleeding210715-vi.jpg"While bleeding is actually a common complication connected with anticoagulants, it has been alleged that Xarelto is a lot more hazardous than classic blood thinners since no antidote exists to reverse its blood-thinning effects. This indicates that, inside the occasion of an emergency, patients might be at risk for irreversible bleeding troubles, such as life-threatening internal and gastrointestinal hemorrhaging.













In case you or even a loved 1 suffered a severe bleeding event following taking Xarelto, you might have legal recourse. For far more information, make contact with us nowadays to have your case reviewed, free of charge.






Compensation Possibilities













xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for previous and future medical bills, lost wages, pain and suffering and, in instances of death, funeral expenses. Furthermore, they're searching for punitive damages, that are normally awarded to punish the defendant and deter other firms from acting similarly.






Why Are Lawsuits Becoming Filed?













Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. simply click the up coming internet page because of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding in the event of an emergency. Plaintiffs in the lawsuits allege severe and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.













In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:













The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.






The makers of the drug continue to market Xarelto as a safe anticoagulant option.






Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the occasion of a bleeding complication.






Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.






Xarelto is linked to critical bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting.













image class="left" url="http://media4.picsearch.com/is?z8xv8jxlMJkmFu5MG3t5LE4FaLt4VP999Jvv_BujdtU&height=192"Visit this page for more info on the alleged health risks of Xarelto.






Multidistrict Litigation Trial Dates Set













The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
There are no comments on this page.
Valid XHTML :: Valid CSS: :: Powered by WikkaWiki